107 related articles for article (PubMed ID: 30614533)
1. Characterization of the epithelial membrane protein 3 interaction network reveals a potential functional link to mitogenic signal transduction regulation.
Christians A; Poisel E; Hartmann C; von Deimling A; Pusch S
Int J Cancer; 2019 Jul; 145(2):461-473. PubMed ID: 30614533
[TBL] [Abstract][Full Text] [Related]
2. EMP3 sustains oncogenic EGFR/CDK2 signaling by restricting receptor degradation in glioblastoma.
Martija AA; Krauß A; Bächle N; Doth L; Christians A; Krunic D; Schneider M; Helm D; Will R; Hartmann C; Herold-Mende C; von Deimling A; Pusch S
Acta Neuropathol Commun; 2023 Nov; 11(1):177. PubMed ID: 37936247
[TBL] [Abstract][Full Text] [Related]
3. Targeting EMP3 suppresses proliferation and invasion of hepatocellular carcinoma cells through inactivation of PI3K/Akt pathway.
Hsieh YH; Hsieh SC; Lee CH; Yang SF; Cheng CW; Tang MJ; Lin CL; Lin CL; Chou RH
Oncotarget; 2015 Oct; 6(33):34859-74. PubMed ID: 26472188
[TBL] [Abstract][Full Text] [Related]
4. Epithelial membrane protein 3 regulates TGF-β signaling activation in CD44-high glioblastoma.
Jun F; Hong J; Liu Q; Guo Y; Liao Y; Huang J; Wen S; Shen L
Oncotarget; 2017 Feb; 8(9):14343-14358. PubMed ID: 27527869
[TBL] [Abstract][Full Text] [Related]
5. Epithelial membrane protein 3 regulates lung cancer stem cells via the TGF‑β signaling pathway.
Kahm YJ; Kim RK; Jung U; Kim IG
Int J Oncol; 2021 Oct; 59(4):. PubMed ID: 34476496
[TBL] [Abstract][Full Text] [Related]
6. Epithelial membrane protein 3 functions as an oncogene and is regulated by microRNA-765 in primary breast carcinoma.
Hong XC; Fen YJ; Yan GC; Hong H; Yan CH; Bing LW; Zhong YH
Mol Med Rep; 2015 Nov; 12(5):6445-50. PubMed ID: 26398721
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of microRNA-4295 enhances cisplatin-induced gastric cancer cell apoptosis through the EGFR/PI3K/Akt signaling pathway by targeting LRIG1.
Yan R; Li K; Yuan DW; Wang HN; Zhang Y; Dang CX; Zhu K
Int J Oncol; 2018 Dec; 53(6):2566-2578. PubMed ID: 30320337
[TBL] [Abstract][Full Text] [Related]
8. Potential significance of EMP3 in patients with upper urinary tract urothelial carcinoma: crosstalk with ErbB2-PI3K-Akt pathway.
Wang YW; Li WM; Wu WJ; Chai CY; Liu HS; Lai MD; Chow NH
J Urol; 2014 Jul; 192(1):242-51. PubMed ID: 24333112
[TBL] [Abstract][Full Text] [Related]
9. Epithelial membrane protein 3 is frequently shown as promoter methylation and functions as a tumor suppressor gene in non-small cell lung cancer.
Xue Q; Zhou Y; Wan C; Lv L; Chen B; Cao X; Ju G; Huang Y; Ni R; Mao G
Exp Mol Pathol; 2013 Dec; 95(3):313-8. PubMed ID: 23920144
[TBL] [Abstract][Full Text] [Related]
10. EMP3, a myelin-related gene located in the critical 19q13.3 region, is epigenetically silenced and exhibits features of a candidate tumor suppressor in glioma and neuroblastoma.
Alaminos M; Dávalos V; Ropero S; Setién F; Paz MF; Herranz M; Fraga MF; Mora J; Cheung NK; Gerald WL; Esteller M
Cancer Res; 2005 Apr; 65(7):2565-71. PubMed ID: 15805250
[TBL] [Abstract][Full Text] [Related]
11. EMP3 negatively modulates breast cancer cell DNA replication, DNA damage repair, and stem-like properties.
Zhou K; Sun Y; Dong D; Zhao C; Wang W
Cell Death Dis; 2021 Sep; 12(9):844. PubMed ID: 34511602
[TBL] [Abstract][Full Text] [Related]
12. TNF-α inhibits the migration of oral squamous cancer cells mediated by miR-765-EMP3-p66Shc axis.
Zheng Z; Luan X; Zha J; Li Z; Wu L; Yan Y; Wang H; Hou D; Huang L; Huang F; Zheng H; Ge L; Guan H
Cell Signal; 2017 Jun; 34():102-109. PubMed ID: 28336231
[TBL] [Abstract][Full Text] [Related]
13. HER2/EGFR-AKT Signaling Switches TGFβ from Inhibiting Cell Proliferation to Promoting Cell Migration in Breast Cancer.
Huang F; Shi Q; Li Y; Xu L; Xu C; Chen F; Wang H; Liao H; Chang Z; Liu F; Zhang XH; Feng XH; Han JJ; Luo S; Chen YG
Cancer Res; 2018 Nov; 78(21):6073-6085. PubMed ID: 30171053
[TBL] [Abstract][Full Text] [Related]
14. Disruption of the tumour-associated EMP3 enhances erythroid proliferation and causes the MAM-negative phenotype.
Thornton N; Karamatic Crew V; Tilley L; Green CA; Tay CL; Griffiths RE; Singleton BK; Spring F; Walser P; Alattar AG; Jones B; Laundy R; Storry JR; Möller M; Wall L; Charlewood R; Westhoff CM; Lomas-Francis C; Yahalom V; Feick U; Seltsam A; Mayer B; Olsson ML; Anstee DJ
Nat Commun; 2020 Jul; 11(1):3569. PubMed ID: 32678083
[TBL] [Abstract][Full Text] [Related]
15. Involvement of smad2 and Erk/Akt cascade in TGF-β1-induced apoptosis in human gingival epithelial cells.
Yoshimoto T; Fujita T; Kajiya M; Matsuda S; Ouhara K; Shiba H; Kurihara H
Cytokine; 2015 Sep; 75(1):165-73. PubMed ID: 25882870
[TBL] [Abstract][Full Text] [Related]
16. PLAUR Confers Resistance to Gefitinib Through EGFR/P-AKT/Survivin Signaling Pathway.
Zhou J; Kwak KJ; Wu Z; Yang D; Li J; Chang M; Song Y; Zeng H; Lee LJ; Hu J; Bai C
Cell Physiol Biochem; 2018; 47(5):1909-1924. PubMed ID: 29961070
[TBL] [Abstract][Full Text] [Related]
17. EMP3 overexpression in primary breast carcinomas is not associated with epigenetic aberrations.
Zhou W; Jiang Z; Li X; Xu F; Liu Y; Wen P; Kong L; Hou M; Yu J
J Korean Med Sci; 2009 Feb; 24(1):97-103. PubMed ID: 19270820
[TBL] [Abstract][Full Text] [Related]
18. Differential roles of ERK and Akt pathways in regulation of EGFR-mediated signaling and motility in prostate cancer cells.
Gan Y; Shi C; Inge L; Hibner M; Balducci J; Huang Y
Oncogene; 2010 Sep; 29(35):4947-58. PubMed ID: 20562913
[TBL] [Abstract][Full Text] [Related]
19. Distinct functional roles of Akt isoforms for proliferation, survival, migration and EGF-mediated signalling in lung cancer derived disseminated tumor cells.
Grabinski N; Bartkowiak K; Grupp K; Brandt B; Pantel K; Jücker M
Cell Signal; 2011 Dec; 23(12):1952-60. PubMed ID: 21777670
[TBL] [Abstract][Full Text] [Related]
20. Matuzumab and cetuximab activate the epidermal growth factor receptor but fail to trigger downstream signaling by Akt or Erk.
Yoshida T; Okamoto I; Okabe T; Iwasa T; Satoh T; Nishio K; Fukuoka M; Nakagawa K
Int J Cancer; 2008 Apr; 122(7):1530-8. PubMed ID: 18033688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
